12 March 2021 · Following the review of stability for cytotoxic drugs for the NHS tender, these monographs are designed to capture the information in a format that is…
15 December 2020 · Following the review of stability for cytotoxic drugs for the NHS tender, these monographs are designed to capture the information in a format that is…
9 September 2020 · MHRA Guidance Note provides advice on the manufacture, importation, distribution and supply of unlicensed medicinal products for human use.
8 September 2020 · No, the PGD framework does not allow for unlicensed medicines to be supplied and /or administered. For example, imported medicines (e.g. licensed in another country…
22 September 2020 · 22 September 2020 13.00 – 14.00 During the Covid emergency, unlicensed and other imported medicines were used as substitutes for critical care licensed medicines to…
8 January 2020 · The below summary details the legal position regarding the sale, supply or administration of off-label/ unlicenced products under Schedule 17 of the HMR 2012
10 October 2019 · A joint statement from the Neonatal and Paediatric Pharmacists' Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH)
18 September 2019 · This document aims to provide guidance to NHS Chief Pharmacists and Accountable Pharmacists working under the Section 10 exemption to the Medicines Act 1968 on…
2 April 2019 · This document provides guidance and advice which is still relevant to the NHS today, on the application of the licensing provisions of the Medicines Act…